The body weight decreased by 10–20% in azoxymethane (AOM)/dextran sodium sulfate (DSS) mice and in those treated with anti TNF-α Ab infliximab (AOM/DSS/Ab), and both groups also developed diarrhea and rectal bleeding when administered with DSS water (data not shown). This evidence concerns the gene TNF and infectious otitis media.